H.R. 6513 — Introduced in House

I 117th CONGRESS 2d Session H. R. 6513 IN THE HOUSE OF REPRESENTATIVES January 28, 2022Mr. Biggs introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes. 1. Short title This Act may be cited as the Medical Innovation Acceleration Act of 2022. 2. Exempting non-invasive diagnostic devices from regulation as devices Section 201(h) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(h)) is amended— (1) in the second sentence by inserting before the period at the end the following: or any non-invasive diagnostic device; and (2) by adding at the end the following: For purposes of the preceding sentence, the term non-invasive means, with respect to a diagnostic device, that the device does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation..